|Full Text Guidelines||Summary of Changes||Scientific Publications & Appendices||Pocket Guidelines||Archive||Panel|
The European Association of Urology (EAU) Sexual and Reproductive Health Guidelines aim to provide a comprehensive overview of the medical aspects relating to sexual and reproductive health in adult men. These Guidelines cover the former EAU Guidelines on Male Sexual Dysfunction, Male Infertility and Male Hypogonadism.
It must be emphasised that guidelines present the best evidence available to the experts. However following guideline recommendations will not necessarily result in the best outcome. Guidelines can never replace clinical expertise when making treatment decisions for individual patients, but rather help to focus decisions - while taking personal values and preferences/individual circumstances of patients into account. Guidelines are not mandates and do not purport to be a legal standard of care.
The EAU Sexual and Reproductive Health Guidelines Panel consists of an international multi-disciplinary group of urologists, endocrinologists and a psychologist. All experts involved in the production of this document have submitted potential conflict of interest statements which can be viewed on the EAU website: http://www.uroweb.org/guideline/sexualandreproductivehealth/.
Alongside the full text version, a quick reference document (Pocket Guidelines) is available in print and as an app for iOS and android devices. These are abridged versions that may require consultation together with the full text version. All documents can be viewed through the EAU website: http://www.uroweb.org/guideline/sexualandreproductivehealth/.
This document is a further update of the 2020 Guidelines which already included a comprehensive update of the 2018 versions of Male Sexual Dysfunction, Male Infertility and Male Hypogonadism guidelines, along with several new topics. Additional sections will be added in the coming years to address male contraception, vasectomy, and penile cosmetic surgery, which have not been previously addressed.
The results of ongoing and new systematic reviews have been included in the 2021 update of the Sexual and Reproductive Health Guidelines. Systematic reviews undertaken in 2020 were:
- What is the effectiveness of non-surgical therapies in the treatment of ischaemic priapism in patients with sickle cell disease?
- What is the effectiveness of non-surgical therapies in the management of priapism in patients without sickle cell disease?
- What is the effectiveness of surgical therapies in the treatment of priapism?